Role of Vitamin A Supplementation in Prevention and Control of Coronavirus Disease‑19: A Narrative Review

Nikita Singh, Harsh Vardhan Chawla, Arun Kumar, Sangeeta Singh

Abstract


Coronavirus disease‑19 (COVID‑19) caused by SARS‑CoV‑2 is a novel viral infectious disease, which broke out in the end of winter season 2019 in China and soon became a pandemic. Characteristically there was severe local and systemic immune‑inflammatory response to the virus, damaging the respiratory system and other organ systems. The morbidity and mortality caused by the disease are producing tremendous impact on health. The understanding about pathogenesis and manifestations of the disease was obscure. To date, no classic treatment or preventive measure was available for COVID‑19 other than symptomatic and supportive care or few drugs under trial. A possibility exists that maintaining vitamin A adequate levels can protect the affected respiratory mucosa, increase antimicrobial activity, produce better antibody response, and have antiinflammatory effects, thereby promoting repair and healing as well. It has been discussed in the review that by various mechanisms, immune regulation through vitamin A supplementation is beneficial to boost immunity in the current outbreak situation when the population is susceptible to the disease. There is a high possibility that vitamin A supplementation to cases as well as population at risk of COVID‑19 has a key role in prevention and control. Hence, it is believed that along with other therapeutic and preventive measures, maintaining vitamin A sufficiency during and prior to the development of active disease may act as an adjuvant in population at risk and cases to prevent and control COVID‑19.

Keywords


Antiinflammatory; COVID‑19; immunomodulation; SARS‑CoV‑2; vitamin A supplementation

Full Text:

PDF

References


World Health Organization. Novel Coronavirus (2019‑nCoV):

Situation report‑11. c2020. [Last accessed on 2020 Apr 23].

Available from: https://www.who.int/emergencies/diseases/

novel‑coronavirus‑2019/situation‑reports.

McDowell EM, Keenan KP, Huang M. Effects of vitamin

A‑deprivation on hamster tracheal epithelium: A quantitative

morphologic study. Virchows Arch B Cell Pathol Incl Mol Pathol

;45:197‑219.

Wong YC, Buck RC. An electron microscopic study of

metaplasia of the rat tracheal epithelium in vitamin A deficiency.

Lab Invest 1971;24:55‑66.

Rojanapo W, Lamb AJ, Olson JA. The prevalence, metabolism

and migration of goblet cells in rat intestine following the

induction of rapid, synchronous vitamin A deficiency. J Nutr

;110:178‑88.

Warden RA, Strazzari MJ, Dunkley PR, O’Loughlin EV. Vitamin

A‑deficient rats have only mild changes in jejunal structure and

function. J Nutr 1996;126:1817‑26.

Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of vitamin A in

the immune system. J Clin Med 2018;7:258.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical

features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497‑506.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al.

Epidemiological and clinical characteristics of 99 cases of 2019

novel coronavirus pneumonia in Wuhan, China: A descriptive

study. Lancet 2020;395:507‑13.

Yoshikawa T, Hill T, Li K, Peters CJ, Tseng CT. Severe acute

respiratory syndrome (SARS) coronavirus‑induced lung epithelial

cytokines exacerbate SARS pathogenesis by modulating intrinsic

functions of monocyte‑derived macrophages and dendritic cells.

J Virol 2009;83:3039‑48.

Channappanavar R, Zhao J, Perlman S. T cell‑mediated

immune response to respiratory coronaviruses. Immunol Res

;59:118‑28.

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al.

Dysregulation of immune response in patients with Coronavirus

(COVID‑19) in Wuhan, China. Clin Infect Dis

;71:762‑8.

Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. Pathogenic

T cells and inflammatory monocytes incite inflammatory storm

in severe COVID‑19 patients. Natl Sci Rev 2020:nwaa041.

Published online 2020. doi: 10.1093/nsr/nwaa041.

Small BA, Dressel SA, Lawrence CW, Drake 3rd DR,

Stoler MH, Enelow RI, et al. CD8(+) T cell‑mediated injury

in vivo progresses in the absence of effector T cells. J Exp Med

;194:1835‑46.

Yuki K, Fujiogi M, Koutsogiannaki S. COVID‑19

pathophysiology: A review. Clin Immunol 2020;215:108427.

Ferrero‑Miliani L, Nielsen OH, Andersen PS, Girardin SE.

Chronic inflammation: Importance of NOD2 and NALP3

in interleukin‑1beta generation. Clin Exp Immunol

;147:227‑35.

Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor

that identifies a novel retinoic acid response pathway. Nature

;345:224‑9.

Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic

acid receptor which belongs to the family of nuclear receptors.

Nature 1987;330:444‑50.

Stephensen CB. Vitamin A, infection, and immune function.

Annu Rev Nutr 2001;21:167‑92.

Wolbach SB, Howe PR. Tissue changes following deprivation of

fat‑soluble a vitamin. J Exp Med 1925;42:753‑77.

Green HN, Mellanby E. Vitamin a as an anti‑infective agent. Br

Med J 1928;2:691‑6.

Thorne‑Lyman A, Fawzi WW. Vitamin A supplementation,

infectious disease and child mortality: A summary of the

evidence. Nestle Nutr Inst Workshop Ser 2012;70:79‑90.

Semba RD. Vitamin A and immunity to viral, bacterial and

protozoan infections. Proc Nutr Soc 1999;58:719‑27.

Wilson JR, DuBOIS RO. Report of a fatal case of keratomalacia

in an infant, with postmortem examination. Am J Dis Child

;26:431‑46.

Blackfan KD, Wolbach SB. Vitamin a deficiency in infants:

A clinical and pathological study. J Pediatr 1933;3:679‑706.

Keenum DG, Semba RD, Wirasasmita S, Natadisastra G,

Muhilal S, West Jr KP, et al. Assessment of vitamin A status

by a disk applicator for conjunctival impression cytology. Arch

Ophthalmol 1990;108:1436‑41.

Natadisastra G, Wittpenn JR, West KP Jr, Muhilal, Sommer A.

Impression cytology for detection of vitamin A deficiency. Arch

Ophthalmol 1987;105:1224‑8.

Qi YJ, Niu QL, Zhu XL, Zhao XZ, Yang WW, Wang XJ.

Relationship between deficiencies in vitamin A and E and

occurrence of infectious diseases among children. Eur Rev Med

Pharmacol Sci 2016;20:5009‑12.

Villamor E, Fawzi WW. Vitamin A supplementation:

Implications for morbidity and mortality in children. J Infect Dis

;182(Suppl 1):S122‑33.

Barreto ML, Santos LM, Assis AM, Araújo MP, Farenzena GG,

Santos PA, et al. Effect of vitamin A supplementation on

diarrhoea and acute lower‑respiratory‑tract infections in young

children in Brazil. Lancet 1994;344:228‑31.

Nikawa T, Odahara K, Koizumi H, Kido Y, Teshima S,

Rokutan K, et al. Vitamin A prevents the decline in

immunoglobulin A and Th2 cytokine levels in small intestinal

mucosa of protein‑malnourished mice. J Nutr 1999;129:934‑41.

Twining SS, Schulte DP, Wilson PM, Fish BL, Moulder JE.

Vitamin A deficiency alters rat neutrophil function. J Nutr

;127:558‑65.

Nauss KM, Mark DA, Suskind RM. The effect of vitamin

A deficiency on the in vitro cellular immune response of rats.

J Nutr 1979;109:1815‑23.

Zhao Z, Ross AC. Retinoic acid repletion restores the number of

leukocytes and their subsets and stimulates natural cytotoxicity

in vitamin A‑deficient rats. J Nutr 1995;125:2064‑73.

Miller SC, Kearney SL. Effect of in vivo administration of all

trans‑retinoic acid on the hemopoietic cell populations of the

spleen and bone marrow: Profound strain differences between

A/J and C57BL/6J mice. Lab Anim Sci 1998;48:74‑80.

Cantorna MT, Nashold FE, Hayes CE. Vitamin A deficiency

results in a priming environment conducive for Th1 cell

development. Eur J Immunol 1995;25:1673‑9.

Kim EW, De Leon A, Jiang Z, Radu RA, Martineau AR,

Chan ED, et al. Vitamin A metabolism by dendritic cells triggers

an antimicrobial response against mycobacterium tuberculosis.

mSphere 2019;4:e00327‑19.

Mugusi FM, Rusizoka O, Habib N, Fawzi W. Vitamin A

status of patients presenting with pulmonary tuberculosis

and asymptomatic HIV‑infected individuals, Dar Es Salaam,

Tanzania. Int J Tuberc Lung Dis 2003;7:804‑7.

Ramachandran G, Santha T, Garg R, Baskaran D, Iliayas SA,

Venkatesan P, et al. Vitamin A levels in sputum‑positive

pulmonary tuberculosis patients in comparison with household

contacts and healthy ‘Normals’. Int J Tuberc Lung Dis

;8:1130‑3.

Wheelwright M, Kim EW, Inkeles MS, De Leon A, Pellegrini M,

Krutzik SR, et al. All‑trans retinoic acid triggered antimicrobial

activity against Mycobacterium tuberculosis is dependent on

NPC2. J Immunol 2014;192:2280‑90.

Kańtoch M, Litwińska B, Szkoda M, Siennicka J. Importance

of vitamin A deficiency in pathology and immunology of viral

infections. Rocz Panstw Zakl Hig 2002;53:385‑92.

Ross AC, Stephensen CB. Vitamin A and retinoids in antiviral

responses. FASEB J 1996;10:979‑85.

Dawson HD, Li NQ, DeCicco KL, Nibert JA, Ross AC. Chronic

marginal vitamin A status reduces natural killer cell number and

function in aging lewis rats. J Nutr 1999;129:1510‑7.

Cui D, Moldoveanu Z, Stephensen CB. High‑level dietary

vitamin A enhances T‑helper type 2 cytokine production and

secretory immunoglobulin a response to influenza a virus

infection in BALB/c mice. J Nutr 2000;130:1132‑9.

Reifen R. Vitamin A as an anti‑inflammatory agent. Proc Nutr

Soc 2002;61:397‑400.

Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Engelhardt B,

Graham BS. Serum vitamin A levels in respiratory syncytial

virus infection. J Pediatr 1994;124:433‑6.

Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015;7:4240‑70.

Vellozo NS, Pereira‑Marques ST, Cabral‑Piccin MP, Filardy AA,

Ribeiro‑Gomes FL, Rigoni TS, et al. All‑trans retinoic

acid promotes an M1‑ to M2‑phenotype shift and inhibits

macrophage‑mediated immunity to leishmania major. Front

Immunol 2017;8:1560.

Pereira WF, Ribeiro‑Gomes FL, Guillermo LVC, Vellozo NS,

Montalvão F, Dosreis GA, et al. Myeloid‑derived suppressor cells

help protective immunity to leishmania major infection despite

suppressed T cell responses. J Leukoc Biol 2011;90:1191‑7.

Bakdash G, Vogelpoel LTC, van Capel TMM, Kapsenberg ML,

de Jong EC. Retinoic acid primes human dendritic cells to

induce gut‑homing, IL‑10‑producing regulatory T cells. Mucosal

Immunol 2015;8:265‑78.

Kang BY, Chung SW, Kim SH, Kang SN, Choe YK, Kim TS.

Retinoid‑mediated inhibition of interleukin‑12 production in

mouse macrophages suppresses Th1 cytokine profile in CD4(+)

T cells. Br J Pharmacol 2000;130:581‑6.

Wang X, Allen C, Ballow M. Retinoic acid enhances the

production of IL‑10 while reducing the synthesis of IL‑12 and

TNF‑alpha from LPS‑stimulated monocytes/macrophages. J Clin

Immunol 2007;27:193‑200.

Ho VW, Hofs E, Elisia I, Lam V, Hsu BE, Lai J, et al. All trans

retinoic acid, transforming growth factor β and prostaglandin E2

in mouse plasma synergize with basophil‑secreted interleukin‑4 to

M2 polarize murine macrophages. PLoS One 2016;11:e0168072.

Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue‑resident

macrophages. Nat Immunol 2013;14:986‑95.

Polcz ME, Barbul A. The role of vitamin A in wound healing.

Nutr Clin Pract 2019;34:695‑700.

Akhtar S, Ahmed A, Randhawa MA, Atukorala S, Arlappa N,

Ismail T, et al. Prevalence of vitamin A deficiency in South Asia:

Causes, outcomes, and possible remedies. J Health Popul Nutr

;31:413‑23.

Suri S, Kumar D, Das R. Dietary deficiency of vitamin A among

rural children: A community‑based survey using a food‑frequency

questionnaire. Natl Med J India 2017;30:61‑4.

Campa A, Baum MK, Bussmann H, Martinez SS, Farahani M,

van Widenfelt E, et al. The effect of micronutrient

supplementation on active TB incidence early in HIV infection

in Botswana. Nutr Diet Suppl 2017;2017:37‑45.

Anand PK, Kaul D, Sharma M. Synergistic action of vitamin

D and retinoic acid restricts invasion of macrophages by

pathogenic mycobacteria. J Microbiol Immunol Infect

;41:17‑25.

Mehta S, Fawzi W. Effects of vitamins, including vitamin A, on

HIV/AIDS patients. Vitam Horm 2007;75:355‑83.

Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates

as apparently widely used messengers in the activation of

the NF‑kappa B transcription factor and HIV‑1. EMBO J

;10:2247‑58.

Shivakoti R, Christian P, Yang W‑T, Gupte N, Mwelase N,

Kanyama C, et al. Prevalence and risk factors of micronutrient

deficiencies pre‑ and post‑antiretroviral therapy (ART) among

a diverse multicountry cohort of HIV‑infected adults. Clin Nutr

;35:183‑9.

Fawzi W. Micronutrients and human immunodeficiency virus

type 1 disease progression among adults and children. Clin

Infect Dis 2003;37(Suppl 2):S112‑6.

Mayo‑Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA.

Vitamin A supplements for preventing mortality, illness, and

blindness in children aged under 5: Systematic review and

meta‑analysis. BMJ 2011;343:d5094.

Hu N, Li QB, Zou SY. [Effect of vitamin A as an adjuvant

therapy for pneumonia in children: A meta analysis]. Zhongguo

Dang Dai Er Ke Za Zhi 2018;20:146‑53.

Bhandari N, Bhan MK, Sazawal S. Impact of massive dose of

vitamin A given to preschool children with acute diarrhoea

on subsequent respiratory and diarrhoeal morbidity. BMJ

;309:1404‑7.

Rahman MM, Vermund SH, Wahed MA, Fuchs GJ, Baqui AH,

Alvarez JO. Simultaneous zinc and vitamin A supplementation in

Bangladeshi children: Randomised double blind controlled trial.

BMJ 2001;323:314‑8.

Coutsoudis A, Bobat RA, Coovadia HM, Kuhn L, Tsai WY,

Stein ZA. The effects of vitamin A supplementation on the

morbidity of children born to HIV‑infected women. Am J Public

Health 1995;85:1076‑81.

Ehrenpreis ED, Carlson SJ, Boorstein HL, Craig RM.

Malabsorption and deficiency of vitamin B12 in HIV‑infected

patients with chronic diarrhea. Dig Dis Sci 1994;39:2159‑62.

Soye KJ, Trottier C, Di Lenardo TZ, Restori KH, Reichman L,

Miller Jr WH, et al. In vitro inhibition of mumps virus by

retinoids. Virol J 2013;10:337.

Owusu‑Agyei S, Newton S, Mahama E, Febir LG, Ali M,

Adjei K, et al. Impact of vitamin A with zinc supplementation on

malaria morbidity in Ghana. Nutr J 2013;12:131.